Evaluation of Dexmedetomidine Dosing in Obese Critically Ill Patients.

Sara A AtyiaKeaton S SmetanaMinh C TongMolly J ThompsonKari M CapeCasey C May

Published in: Journal of pharmacy practice (2021)

Dosing dexmedetomidine using AdjBW in obese critically ill patients for ongoing ICU sedation resulted in no statistical difference in the percent of RASS measurements within goal when compared to ABW dosing. Further studies are warranted.

Keyphrases

adipose tissue
weight loss
metabolic syndrome
type diabetes
cardiac surgery
mechanical ventilation
intensive care unit
obese patients
bariatric surgery
case control